𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The molecular genetics of haemophilia A: screening for point mutations in the factor VIII gene using the restriction enzymeTaqI

✍ Scribed by David S. Millar; Barbara Zoll; Uri Martinowitz; Vijay V. Kakkar; David N. Cooper


Publisher
Springer
Year
1991
Tongue
English
Weight
758 KB
Volume
87
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

✦ Synopsis


A combination of Southern blotting and the analysis of polymerase chain reaction (PCR) amplified DNA fragments was used to screen the factor VIII genes of 527 haemophilia A patients for point mutations within TaqI restriction sites. Since this "directed search" strategy yielded only four gene lesions, it was concluded that its efficacy is less than that originally predicted. One novel point mutation was however found in a moderately severe haemophiliac; a CGA (Arg) to CTA (Leu) transversion at codon 2209, an evolutionarily conserved residue in the C2 domain of the factor VIII protein. The remaining three detected lesions, CGA (Arg)----TGA (Term) transitions at codons 2116, 2147 and 2307, respectively, have been reported before and are consistent with recurrent mutation at these hypermutable sites. A number of TaqI restriction site polymorphisms/rare variants were also noted. These variants appear to be population-specific but are nevertheless potentially useful in individual cases as intragenic markers for carrier detection and antenatal diagnosis.


πŸ“œ SIMILAR VOLUMES


Use of denaturing gradient gel blots to
✍ Shari L. Laprise; Elsa K. Mak; Katherine A. Killoran; Lawrence C. Layman; Mark R πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

## Communicated by John A. Phillips III Denaturing gradient gel electrophoresis (DGGE) is commonly used to search for point mutations in DNA fragments amplified in vitro by the polymerase chain reaction (PCR). For the complete detection of mutations in large genes with many exons, the DGGE-PCR app

Mutational-screening in the factor VIII
✍ Katharina MΓΆller-Morlang; Kamiab Tavassoli; Antonin Eigel; Hartmut Pollmann; JΓΌr πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 16 KB πŸ‘ 2 views

Hemophilia A is an X-linked bleeding disease caused by mutations in the coagulation factor VIII gene. The identification and characterization of pathogenic mutations allows the recognition of new mechanisms of functional disturbances of factor VIII. To screen for mutations exons 1-26 of the factor V

Rapid restriction fragment analysis for
✍ Marie-Claude Vohl; Patrick Couture; Sital Moorjani; Ana L. Torres; Claude GagnΓ©; πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 373 KB πŸ‘ 1 views

## Communicated by Lnp.chee Tsui Familial hypercholesterolemia (FH) has an estimated frequency of 1:154 among French Canadians in Northeastern Quebec, compared with 1:500 in most other populations. FH is caused by numerous mutations of the low-density lipoprotein (LDL) receptor gene, but only six

Independent occurrence of the novel Arg2
✍ Bimal D. M. Theophilus; Mohammad S. Enayat; Miyoko Higuchi; Haig H. Kazazian; St πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 1 views

Using chemical mismatch analysis or denaturing gradient gel electrophoresis followed by nucleotide sequencing, we have identified the same G6545A mutation leading to an Arg 2163 His substitution in the factor VIII gene of three haemophiliacs from unrelated families. One of the affected individuals h